Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-04 Sale |
2021-06-09 06:03 am |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
46,424 | $7.0991 | $329,570 | 1,037,280 (Direct) |
View |
| 2021-05-26 Sale(A) |
2021-05-28 7:03 pm |
Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer |
5,000 | $6.4967 | $32,484 | 127,896 (Indirect Direct) |
View |
| 2021-05-26 Sale |
2021-05-28 6:20 pm |
Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer |
5,000 | $6.4967 | $32,484 | 115,720 (Indirect) |
View |
| 2020-12-28 Sale |
2020-12-30 5:00 pm |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
25,000 | $4.5218 | $113,045 | 993,000 (Direct) |
View |
| 2020-12-23 Sale |
2020-12-28 09:15 am |
Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer |
8,000 | $4.7392 | $37,914 | 132,896 (Indirect Direct) |
View |
| 2020-09-28 Sale |
2020-09-30 5:00 pm |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
25,000 | $5.6158 | $140,395 | 1,018,000 (Direct) |
View |
| 2020-07-13 Sale |
2020-07-15 5:00 pm |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
250,000 | $8.1339 | $2,033,475 | 1,043,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-10 Option Award |
2021-06-14 5:56 pm |
N/A N/A |
Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer |
5,535 | $2.35 | 17,711 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:55 pm |
N/A N/A |
Equillium Inc. | EQ | Rothman Joel Chief Development Officer |
7,742 | $2.35 | 22,991 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-09 06:03 am |
N/A N/A |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
14,999 | $2.8 | 1,037,280 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-09 06:03 am |
N/A N/A |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
31,425 | $4.75 | 1,037,280 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-09 06:03 am |
2021-05-19 2030-05-18 |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
46,874 | $0 | 1,037,280 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:18 pm |
N/A 2031-05-26 |
Equillium Inc. | EQ | Pruzanski Mark Director |
20,770 | $0 | 20,770 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:17 pm |
N/A 2031-05-26 |
Equillium Inc. | EQ | McDermott Charles Douglas Director |
20,770 | $0 | 20,770 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:16 pm |
N/A 2031-05-26 |
Equillium Inc. | EQ | MANIAN BALA S Director |
20,770 | $0 | 20,770 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:10 pm |
N/A 2031-05-26 |
Equillium Inc. | EQ | DEMSKI MARTHA J Director |
20,770 | $0 | 20,770 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-05 4:30 pm |
N/A 2031-03-03 |
Equillium Inc. | EQ | Xu Yu (Katherine) Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-02-16 5:22 pm |
N/A N/A |
Equillium Inc. | EQ | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Cui Xiangmin 10% Owner |
0 | $0 | 4,271,423 (Indirect) |
View |
Ownership |
2021-02-05 4:30 pm |
N/A N/A |
Equillium Inc. | EQ | Xu Yu (Katherine) Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-01-29 5:59 pm |
N/A N/A |
Equillium Inc. | EQ | Rothman Joel Chief Development Officer |
0 | $0 | 350,431 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-13 4:20 pm |
N/A 2031-01-10 |
Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer |
450,000 | $0 | 450,000 (Direct) |
View |
Ownership |
2021-01-13 4:19 pm |
N/A N/A |
Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 5:00 pm |
N/A 2031-01-03 |
Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 5:00 pm |
N/A 2031-01-03 |
Equillium Inc. | EQ | Zedelmayer Christine Sr. Vice President and COO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 5:00 pm |
N/A 2031-01-03 |
Equillium Inc. | EQ | BRADBURY DANIEL Executive Chairman 10% Owner |
36,000 | $0 | 36,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 5:00 pm |
N/A 2031-01-03 |
Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 5:00 pm |
N/A 2031-01-03 |
Equillium Inc. | EQ | Steel Bruce D. President and CEO 10% Owner |
245,000 | $0 | 245,000 (Direct) |
View |
| 2020-12-10 Other |
2020-12-11 5:00 pm |
N/A N/A |
Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer |
5,362 | $2.35 | 146,258 (Direct) |
View |
| 2020-12-10 Other |
2020-12-11 5:00 pm |
N/A N/A |
Equillium Inc. | EQ | Zedelmayer Christine Sr. Vice President and COO |
1,097 | $2.35 | 82,574 (Direct) |
View |